Luke leads Gowling WLG's IP Transactional team. With a PhD in Biochemistry, it’s no surprise that Luke’s main focus is the life sciences, a sector he’s been active in for over 20 years, advising on transactions for Big Pharma, small biotech companies and research institutions. Luke also has particular experience of working with European, Japanese and Chinese life sciences companies and his experience covers drafting and negotiating licences, collaboration agreements, product acquisition agreements, clinical trial agreements, and pharma manufacturing agreements. His clients include Astellas, Bial, Eisai, EUSA Pharma, K.U. Leuven, Kyowa Hakko Kirin, Tusk Therapeutics and VIB.
Luke was recognised as a 'patent star' in the IP Stars guide 2017. He is also recommended by Chambers UK for intellectual property and life sciences: transactional, and by The Legal 500 for intellectual property.